Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

83.99

+3.55 (4.41%)

At close: Jul 2, 2026, 4:00 PM EDT

83.90

-0.09 (-0.11%)

After-hours: Jul 2, 2026, 7:46 PM EDT

Arrowhead Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	622.01	829.45	3.55	240.74	243.23	138.29
Revenue Growth (YoY)	14.09%	23258.15%	-98.52%	-1.03%	75.89%	57.16%
Gross Profit	622.01	829.45	3.55	240.74	243.23	138.29
Selling, General & Admin	156.39	123.94	98.76	92.55	124.43	80.98
Research & Development	687.51	607.16	505.87	353.19	297.31	206.34
Total Operating Expenses	843.9	731.1	604.63	445.74	421.74	287.32
Operating Income	-221.9	98.35	-601.08	-205	-178.51	-149.04
Interest Income	46.63	37.29	22.72	15.3	5.03	6.12
Interest Expense	-92.43	-89.36	-32.35	-18.33	-	-
Other Non-Operating Income (Expense)	15.43	5.26	-1.75	1.54	0.77	2.07
Total Non-Operating Income (Expense)	-13.54	-46.81	-11.38	-1.49	5.8	8.19
Pretax Income	-252.26	51.53	-612.46	-206.49	-172.71	-140.85
Provision for Income Taxes	19.6	21.42	-2.77	2.78	3.79	0
Net Income	-271.86	30.11	-609.69	-209.28	-176.49	-140.85
Minority Interest in Earnings	29.05	31.75	-10.2	-4	-0.43	-
Net Income to Common	-300.91	-1.63	-599.49	-205.28	-176.06	-140.85
Shares Outstanding (Basic)	139	134	120	107	105	104
Shares Outstanding (Diluted)	139	134	120	107	105	104
Shares Change (YoY)	9.70%	11.67%	12.21%	1.26%	1.62%	3.00%
EPS (Basic)	-2.15	-0.01	-5.00	-1.92	-1.67	-1.36
EPS (Diluted)	-2.15	-0.01	-5.00	-1.92	-1.67	-1.36
Free Cash Flow	-50.87	156.89	-604.32	-330.63	-188.91	147.75
Free Cash Flow Per Share	-0.37	1.17	-5.05	-3.10	-1.79	1.42
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-35.67%	11.86%	-16927.10%	-85.16%	-73.39%	-107.77%
Profit Margin	-43.71%	3.63%	-17169.60%	-86.93%	-72.56%	-101.85%
FCF Margin	-8.18%	18.91%	-17018.30%	-137.34%	-77.67%	106.84%
EBITDA	-196.52	122.27	-582.49	-192.51	-168.09	-140.77
EBITDA Margin	-31.59%	14.74%	-16403.40%	-79.97%	-69.11%	-101.79%
EBIT	-221.9	98.35	-601.08	-205	-178.51	-149.04
EBIT Margin	-35.67%	11.86%	-16927.10%	-85.16%	-73.39%	-107.77%
Effective Tax Rate	-7.77%	41.56%	0.45%	-1.35%	-2.19%	-0.00%

SEC Filings: 10-K · 10-Q